CEO says Daraprim price drop may force company to 'fire people'

Martin Shkreli, boss of the controversial pharmaceutical company that increased the price of its life-saving drug 50-fold overnight, has claimed slashing the price of the drug may lead him to cut research for "lethal diseases" and force him to fire